Robert Meehan
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- PARP inhibition in cancer therapy
Papers in
- Oncology 31
- Cancer Immunotherapy and Biomarkers 17
- CAR-T cell therapy research 10
- PARP inhibition in cancer therapy 7
-
- DNA Repair Mechanisms 5
- Co-authors
- Alice P. Chen (18 shared papers)James H. Doroshow (20 shared papers)Geraldine O’Sullivan Coyne (18 shared papers)Joshua P. Frederick (7 shared papers)Manish R. Patel (6 shared papers)Martin Gutierrez (4 shared papers)Tal Zaks (5 shared papers)Kristen Hopson (5 shared papers)
- Journals
- Journal of Clinical Oncology (18 papers)Cancer Research (8 papers)Annals of Oncology (4 papers)European Journal of Cancer (2 papers)The Oncologist (2 papers)
- Partner nations
- United StatesAustraliaGermany
In The Last Decade
Robert Meehan
47 papers receiving 776 citations
Peers
Comparison fields: 5 of 67
- Immunology 301
- Oncology 305
- Molecular Biology 444
- Rheumatology 73
- Cancer Research 40
Countries citing papers authored by Robert Meehan
This map shows the geographic impact of Robert Meehan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Meehan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Meehan more than expected).
Fields of papers citing papers by Robert Meehan
This network shows the impact of papers produced by Robert Meehan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Meehan. The network helps show where Robert Meehan may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Meehan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 138 | |
| 2 | 2019 | 117 | |
| 3 | 2020 | 60 | |
| 4 | 2023 | 52 | |
| 5 | 2020 | 49 | |
| 6 | 2016 | 47 | |
| 7 | 2017 | 38 | |
| 8 | 2020 | 37 | |
| 9 | 2012 | 23 | |
| 10 | 2024 | 20 | |
| 11 | 2019 | 20 | |
| 12 | 1995 | 20 | |
| 13 | 2018 | 19 | |
| 14 | 2019 | 18 | |
| 15 | 2023 | 18 | |
| 16 | 2024 | 13 | |
| 17 | 2024 | 13 | |
| 18 | 2019 | 12 | |
| 19 | 2017 | 8 | |
| 20 | 2020 | 7 |
About Robert Meehan
Robert Meehan is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Immunology and Cancer Research, having authored 49 papers that have together received 796 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (17 papers), CAR-T cell therapy research (10 papers), Immunotherapy and Immune Responses (9 papers), Cancer Genomics and Diagnostics (7 papers), PARP inhibition in cancer therapy (7 papers), Cancer Research and Treatments (6 papers), DNA Repair Mechanisms (5 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Immunology (301 citations), Oncology (305 citations), Molecular Biology (444 citations), Rheumatology (73 citations) and Cancer Research (40 citations). Robert Meehan has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Alice P. Chen, James H. Doroshow, Geraldine O’Sullivan Coyne, Joshua P. Frederick, Manish R. Patel, Martin Gutierrez, Tal Zaks, Kristen Hopson, Lamin Juwara and Shivaani Kummar. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Annals of Oncology, European Journal of Cancer and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.